PMID- 37956943
OWN - NLM
STAT- MEDLINE
DCOM- 20231216
LR  - 20231216
IS  - 1872-8227 (Electronic)
IS  - 0168-8227 (Linking)
VI  - 206
DP  - 2023 Dec
TI  - The prevalence of diabetes distress in Chinese patients with type 2 diabetes: A 
      systematic review and meta-analysis.
PG  - 110996
LID - S0168-8227(23)00759-3 [pii]
LID - 10.1016/j.diabres.2023.110996 [doi]
AB  - OBJECTIVE: To systematically evaluate the prevalence of Diabetes Distress (DD) in 
      type 2 diabetes mellitus (T2DM) patients in China. METHODS: The PubMed, PsycInfo, 
      Web of Science, The Cochrane Library, EMBASE, China Knowledge Resource in 
      Integrated Database (CNKI), WanFang Database, Weipu Database (VIP), and Chinese 
      Biomedical Database (CBM) electronic databases were searched from inception to 
      August 2022, for cross-sectional studies, that reported prevalence of DD. 
      RESULTS: This study included 55 articles involving 13,160 patients with T2DM. The 
      pooled prevalence of DD was 53.2%. The results of the subgroup analysis showed 
      that among the five regions in China, the highest prevalence of DD was observed 
      in Central China (66%), while the lowest prevalence was recorded in North China 
      (23%). The highest prevalence of DD was 82% in unmarried people. while the lowest 
      prevalence of DD among outpatients was as low as 42%. The results of 
      meta-regression showed that there was no correlation between the prevalence of DD 
      and the year of publication, the average age of the patients, or the duration of 
      the disease. CONCLUSION: More than half of T2DM patients in China may suffer from 
      DD, which is not conducive to the self-management of diabetes patients. The 
      burden on the healthcare system and the burden of disease on individual patients 
      may increase as a result. Medical staff should pay attention to the monitoring 
      and management of the mental health status of patients with T2DM.
CI  - Copyright (c) 2023 Elsevier B.V. All rights reserved.
FAU - Tang, Fu-You
AU  - Tang FY
AD  - Department of Anesthesiology, Mianyang Central Hospital, School of Medicine, 
      University of Electronic Science and Technology of China, Sichuan, 621900, China.
FAU - Guo, Xin-Tong
AU  - Guo XT
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Zhang, Lu
AU  - Zhang L
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Yuan, Lei
AU  - Yuan L
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Gan, Ting
AU  - Gan T
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Wang, Mei
AU  - Wang M
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Chen, Xu
AU  - Chen X
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Feng, Cen-Cen
AU  - Feng CC
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Qin, Yu
AU  - Qin Y
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Li, Jing
AU  - Li J
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
FAU - Yu, Yu-Feng
AU  - Yu YF
AD  - Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. 
      Electronic address: YuFengYuCDU@163.com.
LA  - eng
PT  - Journal Article
PT  - Meta-Analysis
PT  - Review
PT  - Systematic Review
DEP - 20231111
PL  - Ireland
TA  - Diabetes Res Clin Pract
JT  - Diabetes research and clinical practice
JID - 8508335
SB  - IM
MH  - Humans
MH  - *Diabetes Mellitus, Type 2/epidemiology
MH  - Cross-Sectional Studies
MH  - Prevalence
MH  - Research Design
MH  - China/epidemiology
OTO - NOTNLM
OT  - China
OT  - Diabetes Distress
OT  - Diabetes Mellitus
OT  - Meta-analysis
OT  - Prevalence
OT  - Systematic review
COIS- Declaration of Competing Interest The authors declare that they have no known 
      competing financial interests or personal relationships that could have appeared 
      to influence the work reported in this paper.
EDAT- 2023/11/14 00:42
MHDA- 2023/12/17 09:44
CRDT- 2023/11/13 19:17
PHST- 2023/02/23 00:00 [received]
PHST- 2023/09/29 00:00 [revised]
PHST- 2023/11/08 00:00 [accepted]
PHST- 2023/12/17 09:44 [medline]
PHST- 2023/11/14 00:42 [pubmed]
PHST- 2023/11/13 19:17 [entrez]
AID - S0168-8227(23)00759-3 [pii]
AID - 10.1016/j.diabres.2023.110996 [doi]
PST - ppublish
SO  - Diabetes Res Clin Pract. 2023 Dec;206:110996. doi: 10.1016/j.diabres.2023.110996. 
      Epub 2023 Nov 11.